Caelum Diagnostic Solutions
Caelum Diagnostic Solutions is developing the RPIDx™, a first-in-kind, AI-assisted diagnostic device capable of yielding biopsy results in 5 minutes. This point-of-care device utilizes accepted FLIM-based metabolic activity detection for fully automated diagnosis, eliminating the need for human analysis and reducing patient suffering from waiting times. It is designed for all medical centers diagnosing cancer, including cancer centers, community hospitals, ambulatory surgical centers, interventional radiology clinics, and dermatology/medical offices. The company has a published patent for its technology. The executive team brings extensive experience in oncology technology, medical device innovation, and clinical oncology and pathology.
Caelum Diagnostic Solutions
Caelum Diagnostic Solutions is developing the RPIDx™, a first-in-kind, AI-assisted diagnostic device capable of yielding biopsy results in 5 minutes. This point-of-care device utilizes accepted FLIM-based metabolic activity detection for fully automated diagnosis, eliminating the need for human analysis and reducing patient suffering from waiting times. It is designed for all medical centers diagnosing cancer, including cancer centers, community hospitals, ambulatory surgical centers, interventional radiology clinics, and dermatology/medical offices. The company has a published patent for its technology. The executive team brings extensive experience in oncology technology, medical device innovation, and clinical oncology and pathology.